{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:09:28Z","timestamp":1790690968182,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1053\/j.semperi.2015.12.004","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T15:15:23Z","timestamp":1452870923000},"page":"160-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide"],"prefix":"10.1053","volume":"40","author":[{"given":"Satyan","family":"Lakshminrusimha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne L.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Pt 1","key":"10.1053\/j.semperi.2015.12.004_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib2","first-page":"157","article-title":"Diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"16","author":"Bendapudi","year":"2015","journal-title":"Paediatr Respir Rev"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000399.pub2","article-title":"Nitric oxide for respiratory failure in infants born at or near term","volume":"18","author":"Finer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0095-5108(18)30039-3","article-title":"Pulmonary vascular biology during neonatal transition","volume":"26","author":"Lakshminrusimha","year":"1999","journal-title":"Clin Perinatol"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2011.4184","article-title":"Brief hyperoxia increases mitochondrial oxidation and increases Pde5 activity in fetal pulmonary artery smooth muscle cells","volume":"17","author":"Farrow","year":"2012","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1542\/peds.2004-2780","article-title":"Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"115","author":"Baptista","year":"2005","journal-title":"Pediatrics"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1542\/peds.2004-0525","article-title":"Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"114","author":"Reynolds","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1651-2227.1998.tb01472.x","article-title":"Endothelin-1, atrial natriuretic peptide and pathophysiology of pulmonary hypertension in porcine meconium aspiration","volume":"87","author":"Soukka","year":"1998","journal-title":"Acta Paediatr"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/archdischild-2013-303981","article-title":"Paediatric pulmonary hypertension and sildenafil: current practice and controversies","volume":"98","author":"Wardle","year":"2013","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.201210-1928PP","article-title":"Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension","volume":"187","author":"Abman","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semperi.2015.12.004_bib11","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.113.005698","article-title":"STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension","volume":"129","author":"Barst","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1053\/j.semperi.2015.12.004_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/ajrccm.165.8.2107097","article-title":"Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension","volume":"165","author":"Shekerdemian","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1203\/01.PDR.0000112033.81970.C2","article-title":"Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome","volume":"55","author":"Shekerdemian","year":"2004","journal-title":"Pediatr Res"},{"issue":"19","key":"10.1053\/j.semperi.2015.12.004_bib14","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1161\/CIRCULATIONAHA.108.845909","article-title":"Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia","volume":"123","author":"Luong","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1165\/rcmb.2012-0043OC","article-title":"Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway","volume":"48","author":"Park","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib16","doi-asserted-by":"crossref","first-page":"L109","DOI":"10.1152\/ajplung.00309.2009","article-title":"Superoxide dismutase and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension","volume":"299","author":"Farrow","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCRESAHA.107.161463","article-title":"Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells","volume":"102","author":"Farrow","year":"2008","journal-title":"Circ Res"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2009.06.012","article-title":"Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension","volume":"155","author":"Steinhorn","year":"2009","journal-title":"J Pediatr"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","article-title":"Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease","volume":"154","author":"Mourani","year":"2009","journal-title":"J Pediatr"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/jp.2011.131","article-title":"Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits","volume":"32","author":"Nyp","year":"2012","journal-title":"Journal Perinatol"},{"issue":"8","key":"10.1053\/j.semperi.2015.12.004_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/archdischild-2012-303333","article-title":"The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia","volume":"98","author":"Wardle","year":"2013","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib23","doi-asserted-by":"crossref","first-page":"F369","DOI":"10.1136\/archdischild-2015-308164","article-title":"Sildenafil in bronchopulmonary dysplasia: safe to use","volume":"100","author":"Wardle","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"8","key":"10.1053\/j.semperi.2015.12.004_bib24","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s00246-013-0725-1","article-title":"Sildenafil weaning afterdischarge in infants with congenital diaphragmatic hernia","volume":"34","author":"Behrsin","year":"2013","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/01.PCC.0000113266.26638.AD","article-title":"Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia","volume":"5","author":"Keller","year":"2004","journal-title":"Pediatr Crit Care Med"},{"issue":"suppl 1","key":"10.1053\/j.semperi.2015.12.004_bib26","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1046\/j.0306-5251.2001.00027.x","article-title":"Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality","volume":"53","author":"Nichols","year":"2002","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/004982599238687","article-title":"Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man","volume":"29","author":"Walker","year":"1999","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.2008.177","article-title":"Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period","volume":"85","author":"Mukherjee","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib29","doi-asserted-by":"crossref","first-page":"L595","DOI":"10.1152\/ajplung.00145.2011","article-title":"Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn","volume":"302","author":"Perez","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1086\/674903","article-title":"Hydrocortisone normalizes phosphodiesterase-5 activity in pulmonary artery smooth muscle cells from lambs with persistent pulmonary hypertension of the newborn","volume":"4","author":"Perez","year":"2014","journal-title":"Pulm Circ"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/tropej\/fml018","article-title":"The effect of steroids on the clinical course and outcome of neonates with meconium aspiration syndrome","volume":"53","author":"Tripathi","year":"2007","journal-title":"J Trop Pediatr"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib32","first-page":"663","article-title":"Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells","volume":"61","author":"Busch","year":"2010","journal-title":"J Physiol Pharmacol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1203\/PDR.0b013e3181bce574","article-title":"Regulation of Phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep","volume":"66","author":"Chen","year":"2009","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000088192","article-title":"Neonatal persistent pulmonary hypertension treated with milrinone: four case reports","volume":"89","author":"Bassler","year":"2006","journal-title":"Biol Neonate"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcrc.2006.01.001","article-title":"Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn","volume":"21","author":"McNamara","year":"2006","journal-title":"J Crit Care"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PCC.0b013e31824ea2cd","article-title":"Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide","volume":"14","author":"McNamara","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/S1047951114002698","article-title":"The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension","volume":"26","author":"James","year":"2015","journal-title":"Cardiol Young"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jp.2014.208","article-title":"Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series","volume":"35","author":"James","year":"2015","journal-title":"J Perinatol"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib39","first-page":"139","article-title":"Prostacyclin does not change during an oxygen induced increase in pulmonary blood flow in the fetal lamb","volume":"32","author":"Morin","year":"1988","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1203\/00006450-198812000-00009","article-title":"Indomethacin does not diminish the pulmonary vascular response of the fetus to increased oxygen tension","volume":"24","author":"Morin","year":"1988","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib41","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1152\/jappl.1986.61.6.2088","article-title":"Hyperventilation, alkalosis, prostaglandins, and pulmonary circulation of the newborn","volume":"61","author":"Morin","year":"1986","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/PCC.0b013e3181936aee","article-title":"Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn","volume":"10","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"10.1053\/j.semperi.2015.12.004_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1378\/chest.14-1004","article-title":"Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study","volume":"147","author":"Frantz","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. [comment]","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.semperi.2015.12.004_bib46","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/oxfordjournals.eurheartj.a015478","article-title":"An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension","volume":"18","author":"Mikhail","year":"1997","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","article-title":"Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery","volume":"127","author":"De Wet","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib48","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1152\/jappl.1999.86.4.1160","article-title":"Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension","volume":"86","author":"Hill","year":"1999","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1203\/00006450-199508000-00011","article-title":"Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets","volume":"38","author":"Zobel","year":"1995","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib50","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.98.12040932","article-title":"Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension","volume":"12","author":"De Jaegere","year":"1998","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1067\/mpd.2002.129849","article-title":"Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide","volume":"141","author":"Kelly","year":"2002","journal-title":"J Pediatr"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib52","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/674762","article-title":"Safety of epoprostenol and treprostinil in children less than 12 months of age","volume":"3","author":"McIntyre","year":"2013","journal-title":"Pulm Circ"},{"issue":"9062","key":"10.1053\/j.semperi.2015.12.004_bib53","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(97)24019-5","article-title":"Orally active prostacyclin analogue in primary pulmonary hypertension","volume":"349","author":"Okano","year":"1997","journal-title":"Lancet"},{"issue":"11","key":"10.1053\/j.semperi.2015.12.004_bib54","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1253\/circj.71.1829","article-title":"Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension","volume":"71","author":"Ikeda","year":"2007","journal-title":"Circ J"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1442-200X.2002.01597.x","article-title":"Beraprost sodium for pulmonary hypertension with congenital heart disease","volume":"44","author":"Suzuki","year":"2002","journal-title":"Pediatr Int"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00246-005-0925-4","article-title":"Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease","volume":"26","author":"Limsuwan","year":"2005","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000298137","article-title":"Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: a retrospective chart review","volume":"99","author":"Nakwan","year":"2011","journal-title":"Neonatology"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S1047951103000726","article-title":"Iloprost in persistent pulmonary hypertension of the newborn","volume":"13","author":"Ehlen","year":"2003","journal-title":"Cardiol Young"},{"issue":"10","key":"10.1053\/j.semperi.2015.12.004_bib59","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s13312-013-0263-1","article-title":"Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn","volume":"50","author":"Janjindamai","year":"2013","journal-title":"Indian Pediatr"},{"issue":"12","key":"10.1053\/j.semperi.2015.12.004_bib60","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ppul.22985","article-title":"Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn","volume":"49","author":"Kahveci","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib61","doi-asserted-by":"crossref","first-page":"F186","DOI":"10.1136\/archdischild-2012-303294","article-title":"Prostaglandin E1 use during neonatal transfer: potential beneficial role in persistent pulmonary hypertension of the newborn","volume":"98","author":"Gupta","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib62","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1203\/01.PDR.0000139927.86617.B6","article-title":"Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I\/II open label clinical trial","volume":"56","author":"Sood","year":"2004","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1745-6215-15-486","article-title":"Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials","volume":"15","author":"Sood","year":"2014","journal-title":"Trials"},{"issue":"8495","key":"10.1053\/j.semperi.2015.12.004_bib64","first-page":"1336","article-title":"Inodilators","volume":"1","author":"Opie","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/j.semperi.2015.12.004_bib65","article-title":"Phosphodiesterase inhibitors in the management of persistent pulmonary hypertension of the newborn (PPHN)","volume":"7","author":"Lakshminrusimha","year":"2009"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/PCC.0b013e318250af44","article-title":"\u201cInodilators\u201d in nitric oxide resistant persistent pulmonary hypertension of the newborn.","volume":"14","author":"Lakshminrusimha","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib67","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1203\/01.pdr.0000242343.84510.81","article-title":"Effects of prostacyclin and milrinone on pulmonary hemodynamics in newborn lambs with persistent pulmonary hypertension induced by ductal ligation","volume":"60","author":"Rashid","year":"2006","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib68","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00000542-199904000-00014","article-title":"The pharmacokinetics of milrinone in pediatric patients after cardiac surgery","volume":"90","author":"Bailey","year":"1999","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1053\/j.semperi.2015.12.004_bib69","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/00003246-199511000-00018","article-title":"Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery","volume":"23","author":"Chang","year":"1995","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/mhj.2002.120305","article-title":"Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics","volume":"143","author":"Hoffman","year":"2002","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.semperi.2015.12.004_bib71","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.0000051365.81920.28","article-title":"Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease","volume":"107","author":"Hoffman","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1053\/j.semperi.2015.12.004_bib72","article-title":"Milrinone for persistent pulmonary hypertension of the newborn","volume":"10","author":"Bassler","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib73","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000339108","article-title":"Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients","volume":"102","author":"Patel","year":"2012","journal-title":"Neonatology"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000339112","volume":"102","author":"Giaccone","year":"2012","journal-title":"Neonatology"},{"issue":"11","key":"10.1053\/j.semperi.2015.12.004_bib75","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1055\/s-0035-1548729","article-title":"Short-term outcomes and medical and surgical interventions in infants with congenital diaphragmatic hernia","volume":"32","author":"Grover","year":"2015","journal-title":"Am J Perinatol"},{"issue":"9","key":"10.1053\/j.semperi.2015.12.004_bib76","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1055\/s-0035-1544949","article-title":"Management Practice and Mortality for Infants with Congenital Diaphragmatic Hernia","volume":"32","author":"Malowitz","year":"2015","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpeds.2008.07.059","article-title":"Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants","volume":"154","author":"Paradisis","year":"2009","journal-title":"J Pediatr"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib78","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1136\/adc.2005.092817","article-title":"Population pharmacokinetics and dosing regimen design of milrinone in preterm infants","volume":"92","author":"Paradisis","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib79","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3476(98)70454-8","article-title":"Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock","volume":"132","author":"Lindsay","year":"1998","journal-title":"J Pediatr"},{"issue":"5 Pt 2","key":"10.1053\/j.semperi.2015.12.004_bib80","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1164\/ajrccm\/146.5_Pt_2.S56","article-title":"Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties","volume":"146","author":"Luscher","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib81","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1139\/y03-013","article-title":"Endothelin in the perinatal circulation","volume":"81","author":"Perreault","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib82","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1152\/jappl.1991.71.2.410","article-title":"Mechanisms by which endothelin 1 induces pulmonary vasoconstriction in the rabbit","volume":"71","author":"Mann","year":"1991","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib83","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1152\/jappl.1992.72.5.1730","article-title":"Endothelin-1-induced pulmonary arterial dilation is reduced by N omega-nitro-l-arginine in fetal lambs","volume":"72","author":"Tod","year":"1992","journal-title":"J Appl Physiol"},{"issue":"6 Pt 2","key":"10.1053\/j.semperi.2015.12.004_bib84","first-page":"H1965","article-title":"Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow","volume":"269","author":"Wong","year":"1995","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib85","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1172\/JCI117210","article-title":"Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation","volume":"93","author":"Ivy","year":"1994","journal-title":"J Clin Invest"},{"issue":"1 Suppl","key":"10.1053\/j.semperi.2015.12.004_bib86","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1378\/chest.114.1_Supplement.65S","article-title":"Chronic intrauterine pulmonary hypertension increases preproendothelin-1 and decreases endothelin B receptor mRNA expression in the ovine fetal lung","volume":"114","author":"Ivy","year":"1998","journal-title":"Chest"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/pr.2012.177","article-title":"Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep","volume":"73","author":"Gien","year":"2013","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1203\/00006450-198903000-00006","article-title":"Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb","volume":"25","author":"Wild","year":"1989","journal-title":"Pediatr Res"},{"issue":"5 Pt 1","key":"10.1053\/j.semperi.2015.12.004_bib89","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-3476(06)80020-X","article-title":"Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide","volume":"122","author":"Zayek","year":"1993","journal-title":"J Pediatr"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib90","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1172\/JCI119274","article-title":"Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus","volume":"99","author":"Ivy","year":"1997","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1164\/rccm.200907-1126OC","article-title":"Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity","volume":"182","author":"Keller","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1053\/j.semperi.2015.12.004_bib92","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2007-994352","article-title":"Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn","volume":"13","author":"Kumar","year":"1996","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib93","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0095-5108(18)30291-4","article-title":"Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment","volume":"22","author":"Steinhorn","year":"1995","journal-title":"Clin Perinatol"},{"issue":"9288","key":"10.1053\/j.semperi.2015.12.004_bib94","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.[comment]","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.semperi.2015.12.004_bib95","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/jp.2011.157","article-title":"A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn","volume":"32","author":"Mohamed","year":"2012","journal-title":"J Perinatol"},{"key":"10.1053\/j.semperi.2015.12.004_bib96","first-page":"A13503","article-title":"Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: results of the FUTURE-4 study","volume":"130","author":"Steinhorn","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib97","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.12-2875","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial","volume":"144","author":"Tapson","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib98","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1440-1754.2006.00835.x","article-title":"Combination pharmacotherapy for severe neonatal pulmonary hypertension","volume":"42","author":"Filan","year":"2006","journal-title":"J Paediatr Child Health"},{"issue":"10","key":"10.1053\/j.semperi.2015.12.004_bib99","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/apa.12707","article-title":"l-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants","volume":"103","author":"Fike","year":"2014","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1165\/rcmb.2014-0351OC","article-title":"Rescue treatment with l-citrulline inhibits hypoxia-induced pulmonary hypertension in newborn pigs","volume":"53","author":"Fike","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1053\/j.semperi.2015.12.004_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jjcc.2014.01.003","article-title":"Oral l-citrulline malate in patients with idiopathic pulmonary arterial hypertension and Eisenmenger Syndrome: a clinical trial","volume":"64","author":"Sharif Kashani","year":"2014","journal-title":"J Cardiol"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib102","doi-asserted-by":"crossref","first-page":"L755","DOI":"10.1152\/ajplung.00138.2010","article-title":"Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension","volume":"301","author":"Chester","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib103","doi-asserted-by":"crossref","first-page":"L318","DOI":"10.1152\/ajplung.00062.2009","article-title":"Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus","volume":"297","author":"Chester","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/Y09-092","article-title":"Role of the RhoA\/Rho-kinase pathway in the regulation of pulmonary vasoconstrictor function","volume":"88","author":"Nossaman","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib105","doi-asserted-by":"crossref","first-page":"L656","DOI":"10.1152\/ajplung.00090.2003","article-title":"Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase","volume":"287","author":"Fagan","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1053\/j.semperi.2015.12.004_bib106","doi-asserted-by":"crossref","first-page":"L976","DOI":"10.1152\/ajplung.00512.2005","article-title":"Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung","volume":"291","author":"Parker","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib107","doi-asserted-by":"crossref","first-page":"L680","DOI":"10.1152\/ajplung.00516.2007","article-title":"Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro","volume":"295","author":"Gien","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1053\/j.semperi.2015.12.004_bib108","doi-asserted-by":"crossref","first-page":"L361","DOI":"10.1152\/ajplung.00277.2013","article-title":"Endothelin-1 decreases endothelial PPARgamma signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension","volume":"306","author":"Wolf","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"10.1053\/j.semperi.2015.12.004_bib109","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1164\/rccm.200605-676OC","article-title":"Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension","volume":"174","author":"Lakshminrusimha","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1053\/j.semperi.2015.12.004_bib110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2165\/00003495-198836020-00003","article-title":"A preliminary review of its pharmacological properties and therapeutic use","volume":"36","author":"Young","year":"1988","journal-title":"Drugs"},{"issue":"1","key":"10.1053\/j.semperi.2015.12.004_bib111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:JOPA.0000029488.45177.48","article-title":"A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery","volume":"31","author":"Bailey","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"14","key":"10.1053\/j.semperi.2015.12.004_bib112","first-page":"1","article-title":"Persistent pulmonary hypertension of the newborn","volume":"1","author":"Sharma","year":"2015","journal-title":"Matern Health Neonatol Perinatol BMC"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515001949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:38:15Z","timestamp":1620995895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000515001949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0146000515001949"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2015.12.004","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}